Jamieson Wellness Inc. (JWEL) to Issue Quarterly Dividend of $0.19 on March 15th

Jamieson Wellness Inc. (TSE:JWELGet Free Report) declared a quarterly dividend on Thursday, February 29th, TickerTech reports. Stockholders of record on Friday, March 15th will be paid a dividend of 0.19 per share on Friday, March 15th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend is Thursday, February 29th.

Jamieson Wellness Price Performance

Shares of JWEL stock traded down C$0.74 during mid-day trading on Wednesday, reaching C$30.15. The company’s stock had a trading volume of 60,253 shares, compared to its average volume of 63,773. The company has a market cap of C$1.27 billion, a P/E ratio of 28.53 and a beta of 0.59. The company has a debt-to-equity ratio of 83.69, a quick ratio of 1.08 and a current ratio of 2.56. The firm’s 50-day moving average is C$30.82 and its two-hundred day moving average is C$27.93. Jamieson Wellness has a 1-year low of C$22.10 and a 1-year high of C$34.14.

Wall Street Analyst Weigh In

JWEL has been the subject of several research reports. CIBC raised their price objective on shares of Jamieson Wellness from C$27.00 to C$32.00 and gave the company a “neutral” rating in a research report on Wednesday. Royal Bank of Canada lowered their price target on shares of Jamieson Wellness from C$38.00 to C$35.00 and set an “outperform” rating for the company in a research report on Friday, November 3rd. Scotiabank lowered their price target on shares of Jamieson Wellness from C$35.00 to C$32.00 and set a “sector perform” rating for the company in a research report on Friday, November 3rd. Stifel Nicolaus set a C$45.00 price target on shares of Jamieson Wellness in a research report on Tuesday, November 28th. Finally, National Bankshares lowered their price target on shares of Jamieson Wellness from C$43.50 to C$38.50 and set an “outperform” rating for the company in a research report on Monday, January 8th. Two equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Jamieson Wellness currently has a consensus rating of “Moderate Buy” and an average price target of C$38.22.

Get Our Latest Stock Report on Jamieson Wellness

Insider Buying and Selling at Jamieson Wellness

In other news, Senior Officer John Doherty sold 33,432 shares of the business’s stock in a transaction on Thursday, December 7th. The shares were sold at an average price of C$30.30, for a total value of C$1,013,036.40. In related news, Director Louis Aronne sold 17,430 shares of the business’s stock in a transaction on Monday, December 11th. The shares were sold at an average price of C$30.13, for a total transaction of C$525,104.90. Also, Senior Officer John Doherty sold 33,432 shares of the business’s stock in a transaction on Thursday, December 7th. The stock was sold at an average price of C$30.30, for a total transaction of C$1,013,036.40. Insiders own 0.21% of the company’s stock.

About Jamieson Wellness

(Get Free Report)

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products including vitamins, herbal and mineral nutritional supplements for humans in Canada, the United States of America, and internationally. It operates through Jamieson Brands and Strategic Partners segments.

Further Reading

Dividend History for Jamieson Wellness (TSE:JWEL)

Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.